1. 中国中医科学院广安门医院
2. 中国人民解放军第三〇三医院
3. 首都医科大学
纸质出版:2014
移动端阅览
[1]褚娜利,张新华,方素萍,王文娟,程艳玲,吴志奎.益髓生血颗粒治疗地中海贫血的前瞻性研究[J].中医杂志,2014,55(18):1561-1565.
CHU Nali, ZHANG Xinhua, FANG Suping, et al. A Prospective Study on Yisui Shengxue Granules for Thalassemia[J]. Journal of Traditional Chinese Medicine2014, 55(18): 1561-1565.
[1]褚娜利,张新华,方素萍,王文娟,程艳玲,吴志奎.益髓生血颗粒治疗地中海贫血的前瞻性研究[J].中医杂志,2014,55(18):1561-1565. DOI: 10.13288/j.11-2166/r.2014.18.009.
CHU Nali, ZHANG Xinhua, FANG Suping, et al. A Prospective Study on Yisui Shengxue Granules for Thalassemia[J]. Journal of Traditional Chinese Medicine2014, 55(18): 1561-1565. DOI: 10.13288/j.11-2166/r.2014.18.009.
目的评价益髓生血颗粒治疗地中海贫血的临床疗效。方法采用自身前后对照前瞻性研究方法
对36例地中海贫血患者(HbH病25例、β-地中海贫血11例)给予两个阶段的治疗
第一阶段服用安慰剂
第二阶段服用益髓生血颗粒
两阶段分别服药12周
阶段之间设4周的洗脱期。检测两阶段治疗前后的血液指标[血红蛋白(Hb)、红细胞(RBC)、胎儿血红蛋白(HbF)、血红蛋白H(HbH)]和中医证候评分
并观察两个阶段治疗的有效率。结果 36例地中海贫血患者经益髓生血颗粒治疗后有效率为83.33%
优于安慰剂阶段的19.44%(P<0.01)
治疗后患者Hb升高水平明显优于安慰剂阶段(P<0.05);HbH病患者经益髓生血颗粒治疗后有效率为96.00%
优于安慰剂阶段的24.00%(P<0.01);β-地中海贫血患者经益髓生血颗粒治疗后有效率为54.55%与安慰剂阶段的9.09%差异无统计学意义(P>0.05)。HbH病患者经益髓生血颗粒治疗后
心悸、气短、眩晕、咽干、潮热盗汗、面色萎黄的中医证候评分与治疗前相比明显降低
β-地中海贫血患者经益髓生血颗粒治疗后
气短、眩晕、咽干、潮热盗汗中医证候评分与治疗前比较亦降低(P<0.05或P<0.01)。结论益髓生血颗粒可有效改善地中海贫血患者的临床症状与血液参数
对HbH病、β-地中海贫血均有效
并且HbH病的临床疗效优于β-地中海贫血。
Objective To evaluate the efficacy of Yisui Shengxue Granules( YSSXG) for thalassemia.Methods A self controlled prospective study was conducted.Totally 43 cases of thalassemia( 30 cases of HbH disease and 13 cases of β-thalassemia) were given two-stage treatment.Placebo was given to the patients at the first stage of treatment.YSSXG was given to the patients at the second stage of treatment.The medication lasted for 12 weeks at each of two stages respectively.Four weeks were set as washout period between stages.The levels of hemoglobin( Hb)
red blood cell( RBC)
fetal hemoglobin( HbF)
hemoglobin H( HbH) and traditional Chinese medicine( TCM) syndrome score were detected.The efficacy was observed.Results After two-stage treatment
there were 7 patients shedding and 36 patients( 25 cases of HbH disease and 11 cases of β-thalassemia) remaining.The total effective rate of YSSXG was 83.33%
which was superior to 19.44% of placebo( P < 0.01).The Hb levels in patients treated with YSSXG were significantly higher than those in patients treated with placebo( P <0.05).The effective rate of YSSXG in 25 patients with HbH disease was 96.00%
which was superior to 24.00% of placebo( P < 0.01).The effective rate of YSSXG in 11 patients with β-thalassemia was 54.55%
which was higher than 9.09% of placebo( P > 0.05).The TCM syndrome scores of palpitations
shortness of breath
dizziness
dry throat
hot flashes
night sweats and pale complexion in 25 patients with HbH disease were significantly decreased after the treatment of YSSXG( P < 0.05 or P < 0.01).The TCM syndrome scores of shortness of breath
dizziness
dry throat
hot flashes and night sweats in 11 patients with β-thalassemia were significantly decreased after the treatment of YSSXG( P < 0.05 or P < 0.01).Conclusion YSSXG is effective for thalassemia
especially for HbH disease.
0
浏览量
208
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号